Efficacy of Cal-Cemex as bone substitute for tibial plateau fractures.
Journal
Journal of orthopaedic surgery and research
ISSN: 1749-799X
Titre abrégé: J Orthop Surg Res
Pays: England
ID NLM: 101265112
Informations de publication
Date de publication:
06 Nov 2023
06 Nov 2023
Historique:
received:
03
09
2023
accepted:
25
10
2023
medline:
8
11
2023
pubmed:
7
11
2023
entrez:
6
11
2023
Statut:
epublish
Résumé
Various factors influence treatment and outcomes in tibial plateau fractures. Bone defects are among them. Many materials have been proposed to address this problem: allograft, bone-cements and various bone substitutes (BSM). Cal-Cemex (β-tricalciophosphate and polymethylmethacrylate) is a new hybrid bi-component BSM. A retrospective multicenter study was conducted based on the clinical experience of three European Hospitals, to demonstrate its clinical effectiveness, versatility and safety. From December 2016 to March 2022, 45 displaced tibial plateau fractures were treated with internal fixation and augmentation using Cal-Cemex. The average age was 55.9 years. According to Schatzker classification, we included 13 type II, 24 type III, 3 type V and 4 type VI fractures. The postoperative follow-up (FU) consisted of clinical and radiological examinations at 6 and 12 weeks and 1 year after surgery. A CT scan was performed preoperatively and 1 year after surgery. Full weight bearing was permitted after less than 6 weeks. Clinical data were collected from patient charts, while functional data were evaluated using the Rasmussen knee function score, the KOOS score and the Hospital for Special Surgery knee rating score (HSS), to evaluate the range of motion, axis and functionality of the knee. The average FU was 42.8 months. CT scans taken at 1 year demonstrated a good surface osteointegration without radiolucent lines or osteolysis with good evidence of interdigitation and even bone ingrowth. At 1-year FU, the mean Rasmussen score was 24.7, the mean KOOS score was 90.7 and the mean HSS was 89.9 and the average full weight-bearing period 34.9. No patients had hardware failure or fracture secondary displacement. Cal-Cemex combines biological features and good mechanical performances. It guarantees biocompatibility and osteoconductivity, although it is not fully reabsorbable; β-tricalciophosphate component gives macro- and microporosity that allow fluids to penetrate inside the material, to stimulate bone ingrowth. The study suggests that Cal-Cemex is an option for tibial plateau fractures, where augmentation and support are necessary for early full weight bearing. The absence of major complications, ease of application, the possibility to cut and perforate this material support its extensive use in bone augmentation for trauma cases.
Sections du résumé
BACKGROUND
BACKGROUND
Various factors influence treatment and outcomes in tibial plateau fractures. Bone defects are among them. Many materials have been proposed to address this problem: allograft, bone-cements and various bone substitutes (BSM). Cal-Cemex (β-tricalciophosphate and polymethylmethacrylate) is a new hybrid bi-component BSM. A retrospective multicenter study was conducted based on the clinical experience of three European Hospitals, to demonstrate its clinical effectiveness, versatility and safety.
MATERIALS AND METHODS
METHODS
From December 2016 to March 2022, 45 displaced tibial plateau fractures were treated with internal fixation and augmentation using Cal-Cemex. The average age was 55.9 years. According to Schatzker classification, we included 13 type II, 24 type III, 3 type V and 4 type VI fractures. The postoperative follow-up (FU) consisted of clinical and radiological examinations at 6 and 12 weeks and 1 year after surgery. A CT scan was performed preoperatively and 1 year after surgery. Full weight bearing was permitted after less than 6 weeks. Clinical data were collected from patient charts, while functional data were evaluated using the Rasmussen knee function score, the KOOS score and the Hospital for Special Surgery knee rating score (HSS), to evaluate the range of motion, axis and functionality of the knee.
RESULTS
RESULTS
The average FU was 42.8 months. CT scans taken at 1 year demonstrated a good surface osteointegration without radiolucent lines or osteolysis with good evidence of interdigitation and even bone ingrowth. At 1-year FU, the mean Rasmussen score was 24.7, the mean KOOS score was 90.7 and the mean HSS was 89.9 and the average full weight-bearing period 34.9. No patients had hardware failure or fracture secondary displacement.
DISCUSSION
CONCLUSIONS
Cal-Cemex combines biological features and good mechanical performances. It guarantees biocompatibility and osteoconductivity, although it is not fully reabsorbable; β-tricalciophosphate component gives macro- and microporosity that allow fluids to penetrate inside the material, to stimulate bone ingrowth.
CONCLUSIONS
CONCLUSIONS
The study suggests that Cal-Cemex is an option for tibial plateau fractures, where augmentation and support are necessary for early full weight bearing. The absence of major complications, ease of application, the possibility to cut and perforate this material support its extensive use in bone augmentation for trauma cases.
Identifiants
pubmed: 37932755
doi: 10.1186/s13018-023-04323-1
pii: 10.1186/s13018-023-04323-1
pmc: PMC10626643
doi:
Substances chimiques
Bone Substitutes
0
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
836Informations de copyright
© 2023. The Author(s).
Références
J Bone Joint Surg Br. 2010 May;92(5):687-92
pubmed: 20436007
Emerg Radiol. 2011 Aug;18(4):279-83
pubmed: 21394519
J Bone Joint Surg Br. 2009 Apr;91(4):426-33
pubmed: 19336799
Injury. 2013 Feb;44(2):249-52
pubmed: 23200030
J Bone Joint Surg Am. 1973 Oct;55(7):1331-50
pubmed: 4586086
Science. 1995 Mar 24;267(5205):1796-9
pubmed: 7892603
J Orthop Trauma. 2011 Feb;25(2):90-5
pubmed: 21245711
Chin J Traumatol. 2008 Oct;11(5):288-92
pubmed: 18822192
Clin Orthop Relat Res. 1993 Jul;(292):87-100
pubmed: 8519141
Acta Orthop Traumatol Turc. 2010;44(4):262-9
pubmed: 21252602
J Trauma. 1980 Apr;20(4):342-3
pubmed: 6988603
J Am Acad Orthop Surg. 2001 May-Jun;9(3):210-8
pubmed: 11421578
J Bone Joint Surg Am. 1998 Aug;80(8):1112-24
pubmed: 9730120
J Knee Surg. 2010 Mar;23(1):9-16
pubmed: 20812575
J Biomed Mater Res B Appl Biomater. 2003 Aug 15;66(2):526-31
pubmed: 12861603
J Knee Surg. 2010 Mar;23(1):3-7
pubmed: 20812574
Strategies Trauma Limb Reconstr. 2012 Nov;7(3):163-75
pubmed: 23086660
Eur J Histochem. 2022 Jan 27;66(1):
pubmed: 35083910
J Orthop Res. 2006 Nov;24(11):2080-6
pubmed: 16944472
Chin J Traumatol. 2016 Dec 1;19(6):342-347
pubmed: 28088939
Clin Orthop Relat Res. 1997 Jun;(339):76-81
pubmed: 9186204
J Bone Joint Surg Am. 2006 Jul;88(7):1442-7
pubmed: 16818968
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2009 Nov;23(11):1316-8
pubmed: 19968170
Surgeon. 2021 Oct;19(5):297-309
pubmed: 32958409
Orthop Traumatol Surg Res. 2011 Feb;97(1):44-50
pubmed: 21233036
Skeletal Radiol. 2007 Feb;36(2):145-51
pubmed: 17136560
Orthop Traumatol Surg Res. 2017 Feb;103(1):105-109
pubmed: 27884644
J Bone Joint Surg Am. 2008 Oct;90(10):2057-61
pubmed: 18829901
Clin Biomech (Bristol, Avon). 2003 Nov;18(9):864-70
pubmed: 14527814
BMC Musculoskelet Disord. 2015 May 13;16:115
pubmed: 25968241
J Bone Joint Surg Am. 2001;83-A Suppl 2 Pt 2:98-103
pubmed: 11712842
Am J Orthop (Belle Mead NJ). 2007 Apr;36(4 Suppl):12-7
pubmed: 17547353
Injury. 2017 Oct;48(10):2221-2229
pubmed: 28733042
Spine (Phila Pa 1976). 2003 Jan 15;28(2):134-9
pubmed: 12544929
J Orthop Trauma. 2005 Nov-Dec;19(10):698-702
pubmed: 16314717
Orthop Rev. 1994 Feb;23(2):149-54
pubmed: 8196973
Arch Orthop Trauma Surg. 2001;121(1-2):67-70
pubmed: 11195122
J Bone Joint Surg Am. 2020 Feb 5;102(3):179-193
pubmed: 31809394
J Orthop Sports Phys Ther. 1998 Aug;28(2):88-96
pubmed: 9699158
Arthroscopy. 2004 Dec;20(10):1063-70
pubmed: 15592236
J Biomed Mater Res. 1998 Winter;43(4):451-61
pubmed: 9855204
Injury. 2010 Oct;41(10):986-95
pubmed: 20728882
J Orthop Trauma. 2014 Feb;28(2):97-102
pubmed: 23695375
J Orthop Trauma. 2015 Feb;29(2):85-90
pubmed: 25050747
Clin Orthop Relat Res. 1979 Jan-Feb;(138):94-104
pubmed: 445923
Clin Orthop Relat Res. 1998 Feb;(347):224-8
pubmed: 9520894
Injury. 2013 Jan;44 Suppl 1:S86-94
pubmed: 23351879
J Orthop Trauma. 1992;6(3):340-6
pubmed: 1403254
Arthroscopy. 1997 Oct;13(5):646-51
pubmed: 9343658
Injury. 2010 Nov;41(11):1178-82
pubmed: 20888560
Clin Orthop Relat Res. 2004 Jun;(423):85-92
pubmed: 15232431
J Orthop Trauma. 2007 Jan;21(1):5-10
pubmed: 17211262
J Bone Joint Surg Am. 2008 Jun;90(6):1186-96
pubmed: 18519310
Arch Orthop Trauma Surg. 1996;115(1):45-8
pubmed: 8775710
J Orthop Trauma. 2013 Sep;27(9):e196-200
pubmed: 23287757
J Bone Joint Surg Br. 2005 May;87(5):716-9
pubmed: 15855378
Eur J Histochem. 2017 May 04;61(2):2673
pubmed: 28735526
J Bone Joint Surg Br. 1999 Jul;81(4):647-53
pubmed: 10463738
J Bone Joint Surg Br. 1998 Nov;80(6):959-64
pubmed: 9853485